Follow Up Guidelines
Community Physician Information
As part of its responsibility to establish a coordinated, province-wide program of cancer control, for residents of Saskatchewan, and to support physicians working in the community setting, the Saskatchewan Cancer Agency has prepared these cancer follow-up guidelines, based on the accumulated experiences of this Agency.
The recommendations have been developed by tumour groups comprised of oncologists and hematologists at the Saskatchewan Cancer Agency.
The Guidelines are a statement of consensus of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult the Guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient's care or treatment.
Breast
- Follow Up Guidelines
- Criteria for Discharge
- Discharge Letters:
- For Patients on Aromatase Inhibitor (Anastrozole, Letrozole and Exemestane)
- For Patients on Tamoxifen
- For Patients Not on Any TreatmentPatients Not on Any Treatment
Central Nervous System
B-Cell Chronic Lymphocytic Leukemia (CLL)
- Follow Up Guidelines
- Discharge Care Pathway
- Discharge Letter
Gastro-Intestinal
- Biliary Tract and Gall Bladder Follow Up Guidelines
- Biliary Tract and Gall Bladder Discharge Letter
- Colorectal Follow Up Guidelines
- Colorectal Stage 1 Discharge Letter
- Colorectal Stage 2/3 Discharge Letter
- Gastro-Esophagael Junction Follow Up Guidelines
- Gastro-Esophagael Junction & Gastric Cancer Discharge Letter - Surgery After Chemo or Chemo-Radiotherapy
- Gastro-Esophagael Junction & Gastric Cancer Discharge Letter - Endoscopic Resection
- Esophagel Cancer Discharge Letter
- Hepatocellular Follow Up Guidelines
- Pancreatic Follow Up Guidelines
- Pancreatic Discharge Letter
Genito-Uriinary
- Neoadjuvant Bladder Cancer Discharge Letter
- Non-Metastatic Bladder Cancer Discharge Letter
- Genitourinary Discharge Care Pathway
- Post Prostate Radiotherapy Follow Up
- Localized Prostate Cancer Discharge Letter
- Localized Renal Cancer Following Surgery Discharge Letter
- Seminoma Stage 1, Post Treatment Discharge Letter
- Seminoma Stage IIA and Non-Bulky IIB, Post Treatment Discharge Letter
- Seminoma Stage IIB Bulky, IIC and III, Post Treatment Discharge Letter
Gyne-Oncology
- Cervical Follow Up Guidelines
- Endometrial Follow Up Guidelines
- Gestational Trophoplastic Neoplasia Follow Up Guidelines
- Ovarian Follow Up Guidelines
Head and Neck
- Squamous Cell Follow Up Guidelines
- Squamous Cell Discharge Letter
Hodgkin's Lymphoma
- Follow Up Guidelines
- Discharge Letter
Lung Cancer
- Small Cell Lung Follow Up Guidelines
- Small Cell Lung Discharge Letter
- Non-Small Cell Lung Follow Up Guidelines
- Non-Small Cell Lung Cancer Discharge Letter
- Pathway of Care after Treatment
Melanoma
- Follow Up Guidelines
- Criteria for Discharge
- Discharge Letter
Neuroendocrine
- Follow Up Guidelines
- Discharge Care Pathway
- Discharge Letter
Non-Hodgkin's Lymphoma
- NHL High Grade Follow Up Guidelines
- NHL High Grade Discharge Care Pathway
- NHL High Grade Discharge Letter
- NHL Low Grade Follow Up Guidelines
- NHL Low Grade Discharge Letter
Thyroid
- Follow Up Guidelines
- Discharge Pathway
- Discharge Letter